• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肺转移切除术的国家差异。

National variation in pulmonary metastasectomy for colorectal cancer.

机构信息

Cancer Epidemiology Group, Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.

Department of Thoracic Surgery, St James's University Hospital, Leeds, UK.

出版信息

Colorectal Dis. 2021 Jun;23(6):1306-1316. doi: 10.1111/codi.15506. Epub 2021 Jan 24.

DOI:10.1111/codi.15506
PMID:33368958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8614123/
Abstract

AIM

Evidence on patterns of use of pulmonary metastasectomy in colorectal cancer patients is limited. This population-based study aims to investigate the use of pulmonary metastasectomy in the colorectal cancer population across the English National Health Service (NHS) and quantify the extent of any variations in practice and outcome.

METHODS

All adults who underwent a major resection for colorectal cancer in an NHS hospital between 2005 and 2013 were identified in the COloRECTal cancer data Repository (CORECT-R). All inpatient episodes corresponding to pulmonary metastasectomy, occurring within 3 years of the initial colorectal resection, were identified. Multi-level logistic regression was used to determine patient and organizational factors associated with the use of pulmonary metastasectomy for colorectal cancer, and Kaplan-Meier and Cox models were used to assess survival following pulmonary metastasectomy.

RESULTS

In all, 173 354 individuals had a major colorectal resection over the study period, with 3434 (2.0%) undergoing pulmonary resection within 3 years. The frequency of pulmonary metastasectomy increased from 1.2% of patients undergoing major colorectal resection in 2005 to 2.3% in 2013. Significant variation was observed across hospital providers in the risk-adjusted rates of pulmonary metastasectomy (0.0%-6.8% of patients). Overall 5-year survival following pulmonary resection was 50.8%, with 30-day and 90-day mortality of 0.6% and 1.2% respectively.

CONCLUSIONS

This study shows significant variation in the rates of pulmonary metastasectomy for colorectal cancer across the English NHS.

摘要

目的

有关结直肠癌患者肺转移瘤切除术使用模式的证据有限。本基于人群的研究旨在调查英国国家医疗服务体系(NHS)中结直肠癌患者肺转移瘤切除术的使用情况,并量化实践和结果方面的任何差异程度。

方法

在 COloRECTal cancer data Repository(CORECT-R)中确定了 2005 年至 2013 年期间在 NHS 医院接受结直肠癌主要切除术的所有成年人,并确定了初始结直肠切除术后 3 年内发生的所有肺转移瘤切除术的住院病例。使用多水平逻辑回归确定与结直肠癌肺转移瘤切除术使用相关的患者和组织因素,并使用 Kaplan-Meier 和 Cox 模型评估肺转移瘤切除术后的生存情况。

结果

在整个研究期间,共有 173354 人接受了主要的结直肠切除术,其中 3434 人(2.0%)在 3 年内进行了肺切除术。肺转移瘤切除术的频率从 2005 年接受主要结直肠切除术的患者中 1.2%增加到 2013 年的 2.3%。在医院提供者之间,肺转移瘤切除术的风险调整率存在显著差异(患者的 0.0%-6.8%)。肺切除术后的总体 5 年生存率为 50.8%,30 天和 90 天死亡率分别为 0.6%和 1.2%。

结论

本研究表明,英国 NHS 中结直肠癌肺转移瘤切除术的比率存在显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/c11a4679515c/CODI-23-1306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/7564e210f003/CODI-23-1306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/fc58be986c88/CODI-23-1306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/c5aa643192b9/CODI-23-1306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/c11a4679515c/CODI-23-1306-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/7564e210f003/CODI-23-1306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/fc58be986c88/CODI-23-1306-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/c5aa643192b9/CODI-23-1306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c69/8614123/c11a4679515c/CODI-23-1306-g004.jpg

相似文献

1
National variation in pulmonary metastasectomy for colorectal cancer.结直肠癌肺转移切除术的国家差异。
Colorectal Dis. 2021 Jun;23(6):1306-1316. doi: 10.1111/codi.15506. Epub 2021 Jan 24.
2
Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database.结直肠癌肺转移切除术:基于韩国国家健康保险数据库的回顾性队列研究
Cancer Res Treat. 2021 Oct;53(4):1104-1112. doi: 10.4143/crt.2020.1213. Epub 2021 Jan 15.
3
Repeat pulmonary resection for recurrent lung metastases from colorectal cancer: an analysis of prognostic factors.结直肠癌复发性肺转移的再次肺切除术:预后因素分析
Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):826-30. doi: 10.1093/icvts/ivv382. Epub 2016 Feb 25.
4
A Real-World, Population-Based Analysis of the Outcomes of Colorectal Cancer Patients with Isolated Synchronous Liver or Lung Metastases Treated with Metastasectomy.一项基于真实世界的、以人群为基础的研究,分析了接受转移瘤切除术治疗的孤立性同步肝或肺转移结直肠癌患者的结局。
World J Surg. 2020 May;44(5):1604-1611. doi: 10.1007/s00268-019-05353-9.
5
Role of major resection in pulmonary metastasectomy for colorectal cancer in the Spanish prospective multicenter study (GECMP-CCR).西班牙前瞻性多中心研究(GECMP-CCR)中结直肠癌肺转移的根治性切除术的作用。
Ann Oncol. 2016 May;27(5):850-5. doi: 10.1093/annonc/mdw064. Epub 2016 Feb 18.
6
Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.结直肠癌肝肺转移患者行肝转移灶和肺转移灶切除术与单纯肺转移灶切除术的预后比较。
World J Surg. 2013 Jun;37(6):1315-21. doi: 10.1007/s00268-013-1954-4.
7
Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era.现代化疗时代转移性结直肠癌初次肺转移瘤切除术后的生存情况。
BMC Surg. 2017 May 10;17(1):54. doi: 10.1186/s12893-017-0252-8.
8
Do Repeated Operations for Recurrent Colorectal Lung Metastases Result in Improved Survival?复发性结直肠肺转移行多次手术是否能改善生存?
Ann Thorac Surg. 2018 Aug;106(2):421-427. doi: 10.1016/j.athoracsur.2018.02.065. Epub 2018 Mar 30.
9
Post-pulmonary metastasectomy prognosis after curative resection for colorectal cancer.结直肠癌根治性切除术后肺转移瘤切除术后的预后
Oncotarget. 2017 May 30;8(22):36566-36577. doi: 10.18632/oncotarget.16616.
10
Variation in the Use of Resection for Colorectal Cancer Liver Metastases.结直肠癌肝转移切除术的应用差异。
Ann Surg. 2019 Nov;270(5):892-898. doi: 10.1097/SLA.0000000000003534.

引用本文的文献

1
Neoadjuvant therapy for resectable colorectal cancer pulmonary oligometastases: a retrospective cohort study.可切除的结直肠癌肺寡转移的新辅助治疗:一项回顾性队列研究
Int J Colorectal Dis. 2025 Aug 29;40(1):191. doi: 10.1007/s00384-025-04986-8.
2
Decoding colorectal cancer lung metastasis: a global research odyssey.解读结直肠癌肺转移:一场全球研究之旅。
Front Oncol. 2025 Jul 24;15:1587422. doi: 10.3389/fonc.2025.1587422. eCollection 2025.
3
Where are the inequalities in colorectal cancer care in a country with universal healthcare? A systematic review and narrative synthesis.

本文引用的文献

1
Pulmonary metastasectomy in colorectal cancer: health utility scores by EQ-5D-3L in a randomized controlled trial show no benefit from lung metastasectomy.结直肠癌肺转移切除术:随机对照试验中 EQ-5D-3L 健康效用评分显示肺转移切除术无益。
Colorectal Dis. 2021 Jan;23(1):200-205. doi: 10.1111/codi.15386. Epub 2020 Oct 21.
2
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed.结直肠癌肺转移切除术:93 例随机对照患者的更新分析-对照生存率比之前预期的要好得多。
Colorectal Dis. 2020 Oct;22(10):1314-1324. doi: 10.1111/codi.15113. Epub 2020 Jun 14.
3
在一个拥有全民医保的国家,结直肠癌治疗中的不平等现象在哪里?系统评价和叙述性综合。
BMJ Open. 2024 Jan 3;14(1):e080467. doi: 10.1136/bmjopen-2023-080467.
4
The Resection Rate of Synchronously Detected Liver and Lung Metastasis from Colorectal Cancer Is Low-A National Registry-Based Study.结直肠癌同时性肝肺转移的切除率低——一项基于全国登记处的研究
Cancers (Basel). 2023 Feb 23;15(5):1434. doi: 10.3390/cancers15051434.
5
The Pulmonary Metastasectomy in Colorectal Cancer cohort study: Analysis of case selection, risk factors and survival in a prospective observational study of 512 patients.结直肠癌肺转移切除术队列研究:512 例前瞻性观察研究中病例选择、风险因素和生存分析。
Colorectal Dis. 2021 Jul;23(7):1793-1803. doi: 10.1111/codi.15651. Epub 2021 May 5.
Variation in the Use of Resection for Colorectal Cancer Liver Metastases.
结直肠癌肝转移切除术的应用差异。
Ann Surg. 2019 Nov;270(5):892-898. doi: 10.1097/SLA.0000000000003534.
4
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.寡转移癌症患者立体定向消融放疗与标准姑息治疗的比较(SABR-COMET):一项随机、2 期、开放标签试验。
Lancet. 2019 May 18;393(10185):2051-2058. doi: 10.1016/S0140-6736(18)32487-5. Epub 2019 Apr 11.
5
Expert Consensus Document on Pulmonary Metastasectomy.肺转移瘤切除术专家共识文件
Ann Thorac Surg. 2019 Feb;107(2):631-649. doi: 10.1016/j.athoracsur.2018.10.028. Epub 2018 Nov 23.
6
Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.年龄、贫困程度与特定合并症和英格兰非小细胞肺癌患者接受大手术之间的关联:一项基于人群的研究。
Thorax. 2019 Jan;74(1):51-59. doi: 10.1136/thoraxjnl-2017-211395. Epub 2018 Aug 12.
7
Pulmonary metastasis in rectal cancer: a retrospective study of clinicopathological characteristics of 404 patients in Chinese cohort.直肠癌肺转移:中国队列404例患者临床病理特征的回顾性研究
BMJ Open. 2018 Feb 17;8(2):e019614. doi: 10.1136/bmjopen-2017-019614.
8
Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival.结直肠癌肺转移瘤切除术:影响生存的预后因素分析
J Thorac Dis. 2017 Oct;9(Suppl 12):S1282-S1290. doi: 10.21037/jtd.2017.07.100.
9
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.不可切除结直肠癌肝转移的局部治疗:一项随机II期试验的结果
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx015.
10
Recent improvement of survival prognosis after pulmonary metastasectomy and advanced chemotherapy for patients with colorectal cancer.近期结直肠癌患者肺转移瘤切除术后及晚期化疗后生存预后的改善情况。
Eur J Cardiothorac Surg. 2017 May 1;51(5):869-873. doi: 10.1093/ejcts/ezw401.